Office of the Director, National Institutes of Health; Notice of Public Forums, 46998 [E9-22000]
Download as PDF
<![CDATA[
46998
Federal Register / Vol. 74, No. 176 / Monday, September 14, 2009 / Notices
Matters to be Discussed: The meeting will
convene to address matters related to the
conduct of Study section business and for the
study section to consider safety and
occupational health-related grant
applications. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information: Price
Connor, PhD, NIOSH Health Scientist, 1600
Clifton Road, NE., Mailstop E–20, Atlanta,
Georgia 30333, Telephone (404) 498–2511,
Fax (404) 498–2571.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: September 3, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–21991 Filed 9–11–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
cprice-sewell on DSK2BSOYB1PROD with NOTICES
Office of the Director, National
Institutes of Health; Notice of Public
Forums
Notice is hereby given of two forums
of the working groups of the NIH
Scientific Management Review Board:
Deliberating Organizational Changes
and Effectiveness Working Group and
Substance Use, Abuse and Addition
Working Group. The forums will serve
as the first among a series of sessions for
gathering information on the agency’s
organizational structure and
recommendations for enhancing the
NIH mission through greater agency
flexibility and responsiveness.
The forums will be open to the public,
with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The input from these meetings will be
summarized in a report that will be
presented to the Scientific Management
Review Board in open session at an
upcoming meeting.
Name of Committee: Substance Use,
Abuse, and Addiction Working Group of the
Scientific Management Review Board.
Date: September 23, 2009.
Open: 8 a.m. to 3 p.m.
Agenda: Presentation and discussion will
include an overview of the science of
substance use, abuse, and addiction and the
public health needs in this area of research.
VerDate Nov<24>2008
15:23 Sep 11, 2009
Jkt 217001
Place: National Institutes of Health,
Building 60, Chapel and Lecture Hall, 9000
Rockville Pike, Bethesda, MD 20892.
Name of Committee: Deliberating
Organizational Change and Effectiveness
Working Group of the Scientific Management
Review Board.
Date: September 24, 2009.
Open: 8 a.m. to 3 p.m.
Agenda: Presentations and discussion will
include an overview of NIH mission and
function from scientific and stakeholder
perspectives, including elaboration upon the
principles and attributes fundamental to its
success.
Place: National Institutes of Health,
Building 60, Chapel and Lecture Hall, 9000
Rockville Pike, Bethesda, MD 20892.
Contact Person: Dr. Lyric Jorgenson, PhD,
NIH–AAAS Science and Technology Policy
Fellow, Office of Science Policy, Office of the
Director, NIH, National Institutes of Health,
Building 1, Room 218, MSC 0166, 9000
Rockville Pike, Bethesda, MD 20892,
smrb@mail.nih.gov, (301) 496–6837.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person. The
meeting will also be webcast. The draft
meeting agenda and other information about
the SMRB, including information about
access to the webcast, will be available at
https://smrb.od.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: August 28, 2009.
Lynn Hudson,
Acting Director, Office of Biotechnology
Activities.
[FR Doc. E9–22000 Filed 9–11–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Child Health and Human Development
Council, September 21, 2009, 8 a.m. to
September 21, 2009, 5 p.m., National
Institutes of Health, Building 31, 31
Center Drive, Bethesda, MD 20892
which was published in the Federal
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Register on September 1, 2009, 74 FR
54224.
This notice is being amended to
provide additional attendee viewing and
Videocast access instructions for open
session of Council. In order to facilitate
public attendance at the open session of
Council, reserve seating will be made
available to the first five individuals
reserving seats in the main meeting
room, Conference Room 6. Please
Contact Ms. Lisa Kaeser, Program and
Public Liaison Office, NICHD, at 301–
496–0536 to make your reservation.
Additional seating will be available in
the meeting overflow rooms, Conference
Rooms 7 and 8. Individuals will also be
able to view the meeting via NIH
Videocast. Please go to the following
link for Videocast access instructions at:
https://www.nichd.nih.gov/about/
overview/advisory/nachhd/virtualmeeting-200910.cfm. The meeting is
partially closed to the public.
Dated: September 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–21998 Filed 9–11–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0667]
[FDA 225–09–0010]
Memorandum of Understanding With
Duke University
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is providing
notice of a memorandum of
understanding (MOU) between the Food
and Drug Administration and Duke
University. The purpose of this MOU is
to establish a framework for
collaboration between the Parties and
for pursuing specific collaborative
projects. This collaboration between the
Parties shall be known as the Cardiac
Safety Research Consortium.
DATES: The agreement became effective
August 4, 2009.
FOR FURTHER INFORMATION CONTACT:
Wendy R. Sanhai, Office of the
Commissioner (HZ–1), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–7867,
FAX: 301–827–5891.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 20.108(c),
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 74, Number 176 (Monday, September 14, 2009)]
[Notices]
[Page 46998]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-22000]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Public Forums
Notice is hereby given of two forums of the working groups of the
NIH Scientific Management Review Board: Deliberating Organizational
Changes and Effectiveness Working Group and Substance Use, Abuse and
Addition Working Group. The forums will serve as the first among a
series of sessions for gathering information on the agency's
organizational structure and recommendations for enhancing the NIH
mission through greater agency flexibility and responsiveness.
The forums will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
The input from these meetings will be summarized in a report that
will be presented to the Scientific Management Review Board in open
session at an upcoming meeting.
Name of Committee: Substance Use, Abuse, and Addiction Working
Group of the Scientific Management Review Board.
Date: September 23, 2009.
Open: 8 a.m. to 3 p.m.
Agenda: Presentation and discussion will include an overview of
the science of substance use, abuse, and addiction and the public
health needs in this area of research.
Place: National Institutes of Health, Building 60, Chapel and
Lecture Hall, 9000 Rockville Pike, Bethesda, MD 20892.
Name of Committee: Deliberating Organizational Change and
Effectiveness Working Group of the Scientific Management Review
Board.
Date: September 24, 2009.
Open: 8 a.m. to 3 p.m.
Agenda: Presentations and discussion will include an overview of
NIH mission and function from scientific and stakeholder
perspectives, including elaboration upon the principles and
attributes fundamental to its success.
Place: National Institutes of Health, Building 60, Chapel and
Lecture Hall, 9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Dr. Lyric Jorgenson, PhD, NIH-AAAS Science and
Technology Policy Fellow, Office of Science Policy, Office of the
Director, NIH, National Institutes of Health, Building 1, Room 218,
MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892,
smrb@mail.nih.gov, (301) 496-6837.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person. The meeting will also be
webcast. The draft meeting agenda and other information about the
SMRB, including information about access to the webcast, will be
available at https://smrb.od.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Dated: August 28, 2009.
Lynn Hudson,
Acting Director, Office of Biotechnology Activities.
[FR Doc. E9-22000 Filed 9-11-09; 8:45 am]
BILLING CODE 4140-01-P
